109 related articles for article (PubMed ID: 1321534)
1. [What is reliable in therapy of liver fibrosis?].
Högemann B
Z Gastroenterol; 1992 May; 30(5):333-6. PubMed ID: 1321534
[TBL] [Abstract][Full Text] [Related]
2. Therapy for hepatic fibrosis.
Brenner DA; Alcorn JM
Semin Liver Dis; 1990 Feb; 10(1):75-83. PubMed ID: 2186490
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of hepatic collagen accumulation in experimental liver fibrosis in rats by a new prolyl 4-hydroxylase inhibitor.
Bickel M; Baringhaus KH; Gerl M; Günzler V; Kanta J; Schmidts L; Stapf M; Tschank G; Weidmann K; Werner U
Hepatology; 1998 Aug; 28(2):404-11. PubMed ID: 9696004
[TBL] [Abstract][Full Text] [Related]
4. [Liver fibrosis. 2].
Hahn EG; Ott U; Martini GA
Z Gastroenterol; 1980 Oct; 18(10):507-23. PubMed ID: 6109405
[TBL] [Abstract][Full Text] [Related]
5. Lysyl oxidase and collagenase in experimental acute and chronic liver injury.
Carter EA; McCarron MJ; Alpert E; Isselbacher KJ
Gastroenterology; 1982 Mar; 82(3):526-34. PubMed ID: 6119272
[TBL] [Abstract][Full Text] [Related]
6. Hepatic collagen synthesis in a rat model of cirrhosis, and its modification by colchicine.
Tanner MS; Jackson D; Mowat AP
J Pathol; 1981 Nov; 135(3):179-87. PubMed ID: 6275060
[TBL] [Abstract][Full Text] [Related]
7. [Effects of interferon-alpha on the mRNA expression of procollagen type I and III of hepatic stellate cells and on the deposition of collagen type I and III in fibrotic liver of rats].
Zhang Q; Wang J; Hu M
Zhonghua Yi Xue Za Zhi; 1999 Sep; 79(9):695-8. PubMed ID: 11715461
[TBL] [Abstract][Full Text] [Related]
8. Colchicine treatment of liver fibrosis.
Nikolaidis N; Kountouras J; Giouleme O; Tzarou V; Chatzizisi O; Patsiaoura K; Papageorgiou A; Leontsini M; Eugenidis N; Zamboulis C
Hepatogastroenterology; 2006; 53(68):281-5. PubMed ID: 16608040
[TBL] [Abstract][Full Text] [Related]
9. [Prolyl hydroxylase activity in liver specimens in chronic liver diseases (author's transl)].
Langness U; Clausnitzer H; Verspohl M; Grasedyck K
Med Klin; 1978 Aug; 73(34):1179-82. PubMed ID: 210365
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoids decrease prolyl hydroxylase activity without the cellular accumulation of underhydroxylated collagen.
Counts DF; Rojas FJ; Cutroneo KR
Mol Pharmacol; 1979 Jan; 15(1):99-107. PubMed ID: 218094
[No Abstract] [Full Text] [Related]
11. Dynamics of hepatic collagen synthesis and intracellular degradation of newly synthesized collagen during chronic carbon tetrachloride-induced liver injury in rats.
Koda M; Murawaki Y; Yamamoto H; Kwasaki H
Res Commun Chem Pathol Pharmacol; 1994 May; 84(2):233-44. PubMed ID: 8091008
[TBL] [Abstract][Full Text] [Related]
12. Enzymes of collagen synthesis and type III procollagen amino-propeptide in serum from Nigerians with chronic endomyocardial fibrosis.
Bolarin DM; Andy JJ
Ann Clin Res; 1983 Jun; 15(3):123-7. PubMed ID: 6314867
[TBL] [Abstract][Full Text] [Related]
13. [Hepatic fibrosis and its serum markers].
Okabe K
Rinsho Byori; 1992 Dec; 40(12):1258-64. PubMed ID: 1339165
[TBL] [Abstract][Full Text] [Related]
14. [Colchicine therapy of fibrosing liver diseases--report of a randomized double-blind study].
Reinhardt M; Jorke D; Jahn G; Krombholz B; Müller A; Machnik G; Kunath H
Dtsch Z Verdau Stoffwechselkr; 1986; 46(5):257-75. PubMed ID: 3542496
[TBL] [Abstract][Full Text] [Related]
15. Bleomycin-induced pulmonary fibrosis in the rat. Prevention with an inhibitor of collagen synthesis.
Kelley J; Newman RA; Evans JN
J Lab Clin Med; 1980 Dec; 96(6):954-64. PubMed ID: 6159435
[TBL] [Abstract][Full Text] [Related]
16. Antifibrotic properties of botanicals in chronic liver disease.
Stickel F; Brinkhaus B; Krähmer N; Seitz HK; Hahn EG; Schuppan D
Hepatogastroenterology; 2002; 49(46):1102-8. PubMed ID: 12143213
[TBL] [Abstract][Full Text] [Related]
17. Is serum prolyl 4-hydroxylase useful as noninvasive marker of liver fibrosis in patients with biliary atresia?
Kobayashi H; Tamura T; Yamataka A; Lane GJ; Miyano T
J Pediatr Surg; 2005 Aug; 40(8):1366-7. PubMed ID: 16080952
[No Abstract] [Full Text] [Related]
18. Partial hepatectomy-induced regeneration accelerates reversion of liver fibrosis involving participation of hepatic stellate cells.
Suárez-Cuenca JA; Chagoya de Sánchez V; Aranda-Fraustro A; Sánchez-Sevilla L; Martínez-Pérez L; Hernández-Muñoz R
Exp Biol Med (Maywood); 2008 Jul; 233(7):827-39. PubMed ID: 18445764
[TBL] [Abstract][Full Text] [Related]
19. Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats.
Bruck R; Genina O; Aeed H; Alexiev R; Nagler A; Avni Y; Pines M
Hepatology; 2001 Feb; 33(2):379-86. PubMed ID: 11172339
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests.
Gressner OA; Weiskirchen R; Gressner AM
Clin Chim Acta; 2007 Jun; 381(2):107-13. PubMed ID: 17399697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
